- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01134679
(EASY)-IMProving Adherence to Clopidogrel Trial (IMPACT)) (EASY-IMPACT)
February 13, 2012 updated by: Stéphane Rinfret, Laval University
Telephone Contacts to Improve Adherence to Dual Anti-Platelet Therapy Following Drug-Eluting Stent Implantation; A Randomized Controlled-Trial
The purpose of this study is to test the impact of a multidisciplinary approach to improve the adhesion and persistence to Clopidogrel therapy.
A simple and inexpensive therapy management involving a tighter monitoring of patients by nurses and pharmacists will improve the persistence and adhesion to Clopidogrel and Aspirin after the implantation of drug-eluting stents.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Optimal treatment with Clopidogrel and Aspirin is critical for preventing complications after implantation of drug-eluting stents (DES).
The premature cessation of Clopidogrel is a well recognized factor of thrombosis of stents, especially DES.
Indeed, there remains a large portion of patients that prematurely stop clopidogrel.
No study has demonstrated that a therapeutic management program could improve patient compliance to their antiplatelets.
Through an open-label clinical study, two groups of patients who just received their DES will be compared: one with the usual protocol (consisting of seeing the cardiologist 6 weeks after the intervention) and one with the normal care supplemented by a simple and efficient follow-up (consisting of phone calls at 7 days, 1 month, 6 months and 9 months explaining the importance of antiplatelet therapy, evaluating the health of the patient and well received prescription from the pharmacy).
Patients in both groups will receive a prescription to Clopidogrel and Aspirin (for 1 month), with 11 renewals.
Study Type
Interventional
Enrollment (Actual)
300
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Quebec
-
Québec, Quebec, Canada, G1V 4G5
- Institut de cardiologie et de pneumologie de Québec
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Percutaneous Coronary Intervention with implantation of Drug-Eluting Stent
- Prescription for Plavix and Aspirin
Exclusion Criteria:
- Patients frequenting more than one pharmacy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Phone calls
Disease management with close patient follow-up, using phone calls.
|
Follow up with phone calls
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
the number of days with available Clopidogrel and Aspirin (from pharmacy records)
Time Frame: 1 year
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
the adhesion to Clopidogrel and Aspirin as self-reported by patients
Time Frame: 1 year
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Stephane Rinfret, MD MSc, Fondation IUCPQ
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2009
Primary Completion (Actual)
June 1, 2010
Study Completion (Actual)
June 1, 2011
Study Registration Dates
First Submitted
July 23, 2009
First Submitted That Met QC Criteria
June 1, 2010
First Posted (Estimate)
June 2, 2010
Study Record Updates
Last Update Posted (Estimate)
February 14, 2012
Last Update Submitted That Met QC Criteria
February 13, 2012
Last Verified
February 1, 2012
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20424
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Fundación EPICActive, not recruitingCoronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, CoronarySpain
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Peking Union Medical College HospitalRecruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
Peking Union Medical College HospitalNot yet recruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
IGLESIAS Juan FernandoUniversity of BernNot yet recruiting
-
National Institutes of Health Clinical Center (CC)National Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Arteriosclerosis | Coronary Artery Disease (CAD) | Obstructive Coronary Artery DiseaseUnited States
-
Fundación EPICRecruitingCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Left Main Coronary Artery Disease | Coronary Artery StenosisSpain
-
Barts & The London NHS TrustImperial College London; Brunel UniversityNot yet recruitingCORONARY ARTERY DISEASE
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Chronic Total Occlusion of Coronary Artery | Coronary Restenosis | Coronary Artery Stenosis | Coronary Artery RestenosisBelgium
-
Seung-Jung ParkCardioVascular Research Foundation, KoreaRecruitingCoronary Stenosis | Coronary Artery Bypass Grafting | Coronary Artery Disease Progression | Percutaneous Coronary RevascularizationKorea, Republic of
Clinical Trials on Multi-disciplinary disease management approach
-
Universitair Ziekenhuis BrusselEnrolling by invitationEnteral Nutrition | Parenteral Nutrition | Tube Feeding | Oral AversionBelgium
-
Adana City Training and Research HospitalCompletedObesity | Binge-Eating Disorder | Weight Loss | Group MeetingsTurkey
-
Chinese University of Hong KongQueen Elizabeth Hospital, Hong KongCompleted
-
Peking UniversityUnknownMulti-disciplinary TreatmentChina
-
Beijing Tiantan HospitalThe First Affiliated Hospital of Anhui Medical University; West China Hospital and other collaboratorsRecruitingBrain Arteriovenous MalformationChina
-
Adnan SharifActive, not recruitingPhysical Activity | Hemodialysis Complication | Nutritional DeficiencyUnited Kingdom
-
Chang Gung Memorial HospitalCompletedThe Predictors and Benefits of Multi-discipline Disease Management Program in Heart Failure PatientsHeart Failure With DecompensationTaiwan
-
Beijing Tiantan HospitalRecruitingHeart Failure | Atrial Fibrillation | Ischemic Heart Disease | Cerebral Infarction | Cardiac Arrest | Moyamoya Disease | Subarachnoid Hemorrhage | Aortic Diseases | Cerebral Aneurysm | Intracerebral Hemorrhage | Occlusion and Stenosis of Precerebral Arteries | Occlusion and Stenosis of Cerebellar Arteries | Arteriovenous...China
-
The University of Hong KongRecruitingCardiovascular Diseases | Hypertension | Diabetes Mellitus | Death | Kidney Disease, Chronic | Morbidity, MultipleChina